Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Hayashida Jon K.

2. Date of Event Requiring Statement (MM/DD/YYYY) 6/27/2019

3. Issuer Name and Ticker or Trading Symbol

STAAR SURGICAL CO [STAA]

(Last) (First) (Middle)

25651 ATLANTIC OCEAN DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
VP, Global Clinical, Medical /

(Street)

LAKE FOREST, CA 92630

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	21323 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock Options ⁽²⁾	7/27/2016	7/26/2025	Common Stock Options	50000	$8.64	D
Common Stock Options ⁽³⁾	3/18/2017	3/17/2026	Common Stock Options	25000	$7.52	D
Common Stock Options ⁽⁴⁾	3/21/2018	3/20/2027	Common Stock Options	37500	$9.30	D
Common Stock Options ⁽⁵⁾	3/15/2019	3/14/2028	Common Stock Options	25000	$16.15	D
Common Stock Options ⁽⁶⁾	6/14/2019	6/13/2028	Common Stock Options	13484	$29.80	D
Common Stock Options ⁽⁷⁾	3/14/2020	3/13/2029	Common Stock Options	28026	$35.98	D

Explanation of Responses:
(1)	Includes 6,250 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse on March 21, 2020.
(2)	The options granted became exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (7/27/2015) and the remaining 2/3 vested in thirds on the following two anniversaries of the grant date, subject to continuous employment.
(3)	The options granted became exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/18/2016) and the remaining 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.
(4)	The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/21/2017) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.
(5)	The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/15/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.
(6)	The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (6/14/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.
(7)	The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/14/2019) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Hayashida Jon K. 25651 ATLANTIC OCEAN DRIVE LAKE FOREST, CA 92630			VP, Global Clinical, Medical

Signatures
/s/ Samuel Gesten as attorney-in-fact for Jon Hayashida		7/10/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.